1kv2: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1kv2.gif|left|200px]] | [[Image:1kv2.gif|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_1kv2", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
| | or leave the SCENE parameter empty for the default display. | ||
| | --> | ||
{{STRUCTURE_1kv2| PDB=1kv2 | SCENE= }} | |||
}} | |||
'''Human p38 MAP Kinase in Complex with BIRB 796''' | '''Human p38 MAP Kinase in Complex with BIRB 796''' | ||
| Line 36: | Line 33: | ||
[[Category: Regan, J.]] | [[Category: Regan, J.]] | ||
[[Category: Tong, L.]] | [[Category: Tong, L.]] | ||
[[Category: | [[Category: Protein-inhibitor complex]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 23:12:08 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
Revision as of 23:12, 2 May 2008
Human p38 MAP Kinase in Complex with BIRB 796
OverviewOverview
The p38 MAP kinase plays a crucial role in regulating the production of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1. Blocking this kinase may offer an effective therapy for treating many inflammatory diseases. Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase. The formation of this binding site requires a large conformational change not observed previously for any of the protein Ser/Thr kinases. This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase. Solution studies demonstrate that this class of compounds has slow binding kinetics, consistent with the requirement for conformational change. Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold. One of the most potent compounds in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.
About this StructureAbout this Structure
1KV2 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site., Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, Grob PM, Hickey ER, Moss N, Pav S, Regan J, Nat Struct Biol. 2002 Apr;9(4):268-72. PMID:11896401 Page seeded by OCA on Fri May 2 23:12:08 2008